Continuing Medical Education (CME)

This CME event for optometrists focuses on anti-VEGF therapy for retinal disease and the latest developments in dosing regimens and treatment delivery approaches. The lecture will be presented in a case-based format, providing attendees with practical examples and real-world applications of the material. The lecture will cover novel dosing regimens and treatment delivery approaches, including advances in subretinal gene therapy, intravitreal and topical administration. The lecture will also discuss the use of anti-VEGF therapy for the management of a variety of retinal diseases, such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. Attendees will leave with a better understanding of the latest developments in anti-VEGF therapy for retinal disease and how to effectively counsel patients on these advances in their clinical practices.

This CME event for optometrists focuses on optimizing outcomes in cataract surgery by discussing advances in AI-based intraocular lens (IOL) selection and customizing outcomes for pathological eyes. The event will highlight the use of artificial intelligence in IOL selection to improve precision and accuracy, resulting in better visual outcomes for patients. This discussion will emphasize the emerging role of optometrists in working collaboratively with surgeons to ensure that patients receive the most appropriate treatment and achieve the best possible vision after cataract surgery.